标题
Targeting CD123 in BPDCN: an emerging field
作者
关键词
-
出版物
Expert Review of Hematology
Volume 14, Issue 11, Pages 993-1004
出版商
Informa UK Limited
发表日期
2021-10-07
DOI
10.1080/17474086.2021.1988848
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Targeting the p-D-C: easy as C-D-1-2-3?
- (2021) Naveen Pemmaraju BLOOD
- Central Nervous System Involvement in Blastic Plasmacytoid Dendritic Cell Neoplasm
- (2021) Naveen Pemmaraju et al. BLOOD
- Quick complete response achievement with venetoclax and azacitidine in a case of relapsed disseminated blastic plasmacytoid dendritic cell neoplasm
- (2020) Matteo Piccini et al. ANNALS OF HEMATOLOGY
- Clinical Profile of IMGN632, a Novel CD123-Targeting Antibody-Drug Conjugate (ADC), in Patients with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- (2020) Naval G. Daver et al. BLOOD
- New perspectives in genetics and targeted therapy for blastic plasmacytoid dendritic cell neoplasm
- (2020) Xiang Zhang et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Blastic plasmacytoid dendritic cell neoplasm
- (2020) Kendra Sweet CURRENT OPINION IN HEMATOLOGY
- Tagraxofusp as treatment for patients with blastic plasmacytoid dendritic cell neoplasm
- (2020) Sophia S Lee et al. Expert Review of Anticancer Therapy
- Rapidly Switchable Universal CAR-T cells for Treatment of CD123-positive Leukemia
- (2020) Simon Loff et al. Molecular Therapy-Oncolytics
- Hematopoietic Cell Transplant for Blastic Plasmacytoid Dendritic Cell Neoplasm
- (2020) Mohamed A. Kharfan-Dabaja et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Chemotherapy Options for Blastic Plasmacytoid Dendritic Cell Neoplasm
- (2020) Michael Haddadin et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Tagraxofusp for Blastic Plasmacytoid Dendritic Cell Neoplasm
- (2020) Danielle Hammond et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Novel Therapies for Blastic Plasmacytoid Dendritic Cell Neoplasm
- (2020) Andrew A. Lane HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Recent advances in CAR-T cell engineering
- (2020) Ruihao Huang et al. Journal of Hematology & Oncology
- Tagraxofusp for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): A Brief Report on Emerging Data
- (2020) Guillaume Beziat et al. OncoTargets and Therapy
- Survival outcomes in blastic plasmacytoid dendritic cell neoplasm by first-line treatment and stem cell transplant
- (2020) Seongseok Yun et al. Blood Advances
- Flotetuzumab as Salvage Immunotherapy for Refractory Acute Myeloid Leukemia
- (2020) Geoffrey L Uy et al. BLOOD
- Targeting CD123 in AML
- (2020) Andrew A. Lane Clinical Lymphoma Myeloma & Leukemia
- Tagraxofusp followed by combined azacitidine and venetoclax in blastic plasmacytoid dendritic cell neoplasm: A case report and literature review
- (2020) Yazan Samhouri et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- CD123 as a Biomarker in Hematolymphoid Malignancies: Principles of Detection and Targeted Therapies
- (2020) Hanadi El Achi et al. Cancers
- Approval of tagraxofusp-erzs for blastic plasmacytoid dendritic cell neoplasm
- (2020) Naveen Pemmaraju et al. Blood Advances
- Blastic plasmacytoid dendritic cell neoplasms: results of an international survey on 398 adult patients
- (2020) Kamel Laribi et al. Blood Advances
- Tagraxofusp: First Global Approval
- (2019) Yahiya Y. Syed DRUGS
- Blastic Plasmacytoid Dendritic Cell Neoplasm
- (2019) Daniel Kerr et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm
- (2019) Naveen Pemmaraju et al. NEW ENGLAND JOURNAL OF MEDICINE
- Blastic Plasmacytoid Dendritic Cell Neoplasm: State of the Art and Prospects
- (2019) Maria Rosaria Sapienza et al. Cancers
- PD1/PD-L1 Expression in Blastic Plasmacytoid Dendritic Cell Neoplasm
- (2019) Phyu P. Aung et al. Cancers
- Dual Expression of TCF4 and CD123 is Highly Sensitive and Specific For Blastic Plasmacytoid Dendritic Cell Neoplasm
- (2019) Narittee Sukswai et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Multicenter Analysis of Outcomes in Blastic Plasmacytoid Dendritic Cell Neoplasm Offers a Pre-Targeted Therapy Benchmark
- (2019) Justin Taylor et al. BLOOD
- Blastic Plasmacytoid Dendritic Cell Neoplasm–Current Insights
- (2019) Sangeetha Venugopal et al. Clinical Lymphoma Myeloma & Leukemia
- Promising results with tagraxofusp in BPDCN
- (2019) Elizabeth Gourd LANCET ONCOLOGY
- FDA Approval Summary: Tagraxofusp-erzs For Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm
- (2019) Emily Y. Jen et al. CLINICAL CANCER RESEARCH
- Tagraxofusp, the first CD123-targeted therapy and first targeted treatment for blastic plasmacytoid dendritic cell neoplasm
- (2019) Minas P. Economides et al. Expert Review of Clinical Pharmacology
- CD123 as a Therapeutic Target in the Treatment of Hematological Malignancies
- (2019) Testa et al. Cancers
- DNA methyltransferase inhibition overcomes diphthamide pathway deficiencies underlying CD123-targeted treatment resistance
- (2019) Katsuhiro Togami et al. JOURNAL OF CLINICAL INVESTIGATION
- Role of tagraxofusp in treating blastic plasmacytoid dendritic cell neoplasm (BPDCN)
- (2019) Mansour Alfayez et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Antibody–Drug Conjugates with Indolinobenzodiazepine Dimer Payloads: DNA-Binding Mechanism of Indolinobenzodiazepine Dimer Catabolites in Target Cancer Cells
- (2019) Rajeeva Singh et al. MOLECULAR PHARMACEUTICS
- Updates in Novel Therapies for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- (2019) Minas P. Economides et al. Current Hematologic Malignancy Reports
- First pediatric experience of SL-401, a CD123-targeted therapy, in patients with blastic plasmacytoid dendritic cell neoplasm: report of three cases
- (2018) Weili Sun et al. Journal of Hematology & Oncology
- 8q24/ MYC rearrangement is a recurrent cytogenetic abnormality in blastic plasmacytoid dendritic cell neoplasms
- (2018) Prajwal C. Boddu et al. LEUKEMIA RESEARCH
- The advances in therapy of blastic plasmacytoid dendritic cell neoplasm
- (2018) Daniel Kerr et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Epidemiology and survival of blastic plasmacytoid dendritic cell neoplasm
- (2018) Guru Subramanian Guru Murthy et al. LEUKEMIA RESEARCH
- Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target
- (2018) Maria Rosaria Sapienza et al. HAEMATOLOGICA
- Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia
- (2017) Hagop Kantarjian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Novel Pathways and Potential Therapeutic Strategies for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): CD123 and Beyond
- (2017) Naveen Pemmaraju Current Hematologic Malignancy Reports
- Blastic Plasmacytoid Dendritic Cell Neoplasm: Update on Molecular Biology, Diagnosis, and Therapy
- (2017) Wasif Riaz et al. Cancer Control
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
- (2016) D. A. Arber et al. BLOOD
- A Druggable TCF4- and BRD4-Dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm
- (2016) Michele Ceribelli et al. CANCER CELL
- A critical review of treatment modalities for blastic plasmacytoid dendritic cell neoplasm
- (2016) Umberto Falcone et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Blastic Plasmacytoid Dendritic Cell Neoplasm Is Dependent on BCL2 and Sensitive to Venetoclax
- (2016) Joan Montero et al. Cancer Discovery
- Blastic plasmacytoid dendritic cell neoplasm frequently shows occult central nervous system involvement at diagnosis and benefits from intrathecal therapy
- (2016) Lourdes Martín-Martín et al. Oncotarget
- Treatment of blastic plasmacytoid dendritic cell neoplasm
- (2016) J. M. Sullivan et al. Hematology-American Society of Hematology Education Program
- CAR T Cell Therapy: A Game Changer in Cancer Treatment
- (2016) Hilde Almåsbak et al. Journal of Immunology Research
- Long-term survival following autologous and allogeneic stem cell transplantation for blastic plasmacytoid dendritic cell neoplasm
- (2015) T. Aoki et al. BLOOD
- Targeting CD123 in acute myeloid leukemia using a T-cell-directed dual-affinity retargeting platform
- (2015) M. Al-Hussaini et al. BLOOD
- A CD3xCD123 bispecific DART for redirecting host T cells to myelogenous leukemia: Preclinical activity and safety in nonhuman primates
- (2015) Gurunadh R. Chichili et al. Science Translational Medicine
- Classification and clinical behavior of blastic plasmacytoid dendritic cell neoplasms according to their maturation-associated immunophenotypic profile
- (2015) Lourdes Martín-Martín et al. Oncotarget
- Targeted diphtheria toxin to treat BPDCN
- (2014) D. J. FitzGerald BLOOD
- Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients
- (2014) A. E. Frankel et al. BLOOD
- In vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent
- (2014) F. Angelot-Delettre et al. HAEMATOLOGICA
- Chimeric antigen receptors against CD33/CD123 antigens efficiently target primary acute myeloid leukemia cells in vivo
- (2014) I Pizzitola et al. LEUKEMIA
- TET2mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow
- (2013) Khaled Alayed et al. AMERICAN JOURNAL OF HEMATOLOGY
- T cells expressing CD123-specific chimeric antigen receptors exhibit specific cytolytic effector functions and antitumor effects against human acute myeloid leukemia
- (2013) A. Mardiros et al. BLOOD
- Targeting of acute myeloid leukaemia by cytokine-induced killer cells redirected with a novel CD123-specific chimeric antigen receptor
- (2013) Sarah Tettamanti et al. BRITISH JOURNAL OF HAEMATOLOGY
- Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study
- (2013) L. Pagano et al. HAEMATOLOGICA
- Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation
- (2012) D. Roos-Weil et al. BLOOD
- Blastic Plasmacytoid Dendritic Cell Neoplasia (BPDC) in Elderly Patients: Results of a Treatment Algorithm Employing Allogeneic Stem Cell Transplantation with Moderately Reduced Conditioning Intensity
- (2011) Sascha Dietrich et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Effector Cell Recruitment with Novel Fv-based Dual-affinity Re-targeting Protein Leads to Potent Tumor Cytolysis and in Vivo B-cell Depletion
- (2010) Syd Johnson et al. JOURNAL OF MOLECULAR BIOLOGY
- Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia
- (2009) Francine Garnache-Ottou et al. BRITISH JOURNAL OF HAEMATOLOGY
- Phase I clinical study of diphtheria toxin-interleukin 3 fusion protein in patients with acute myeloid leukemia and myelodysplasia
- (2008) Arthur Frankel et al. LEUKEMIA & LYMPHOMA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started